Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: Data from the heart and soul study

American Journal of Kidney Diseases

Volumn 56, Issue 3, 2010, Pages 496-505

  Saab, Georges ^a,b   Whooley, Mary A ^c,d   Schiller, Nelson B ^c   Ix, Joachim H ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; kidney dysfunction; phosphorus; Sex hormones

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHORUS; SEX HORMONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HORMONE SUBSTITUTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PHOSPHATE BLOOD LEVEL; PREDICTION; RACE; SEX DIFFERENCE; SMOKING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; MIDDLE AGED;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PHOSPHORUS; SEX FACTORS;

EID: 77956225445     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.03.030     Document Type: Article

References (38)

1. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, and F.K. Port Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 4 1998 607 617
2. G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G. Lowrie, and G.M. Chertow Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 8 2004 2208 2218
3. R. Dhingra, L.M. Sullivan, and C.S. Fox Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 9 2007 879 885
4. S.J. Onufrak, A. Bellasi, and F. Cardarelli Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality Am J Epidemiol 169 1 2009 67 77
5. M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, and G. Curhan Relation between serum phosphate level and cardiovascular event rate in people with coronary disease Circulation 112 17 2005 2627 2633
6. S. Jono, M.D. McKee, and C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 7 2000 E10 E17
7. K.L. Adeney, D. Siscovick, and J.H. Ix Association of serum phosphate concentrations with vascular and valvular calcification in moderate chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis J Am Soc Nephrol 20 2009 381 387
8. W.G. Goodman, J. Goldin, and B.D. Kuizon Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 20 2000 1478 1483
9. K.R. Tuttle, and R.A. Short Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function Clin J Am Soc Nephrol 4 12 2009 1968 1973
10. R.N. Foley, A.J. Collins, C.A. Herzog, A. Ishani, and P.A. Kalra Serum phosphorus levels associate with coronary atherosclerosis in young adults J Am Soc Nephrol 20 2 2009 397 404
11. J.H. Ix, I.H. De Boer, and C.A. Peralta Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA Clin J Am Soc Nephrol 4 3 2009 609 615
12. K. Amann, J. Toernig, and B. Kugel Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia Kidney Int 4 63 2003 1296 1301
13. K. Neves, F. Graciolli, L. dos Reis, C. Pasqualucci, R. Moyss, and V. Jorgetti Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure Kidney Int 6 66 2004 2237 2244
14. P. Strzecki, A. Adamowicz, E. Nartowicz, G. Odrowaz-Sypniewska, Z. Wodarczyk, and J. Manitius Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients Ren Fail 1 23 2001 115 126
15. S.J. Onufrak, A. Bellasi, and L.J. Shaw Phosphorus levels are associated with subclinical atherosclerosis in the general population Atherosclerosis 199 2 2008 424 431
16. I.H. de Boer, T.C. Rue, and B. Kestenbaum Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 53 3 2009 399 407
17. S. Faroqui, M. Levi, M. Soleimani, and H. Amlal Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia Kidney Int 73 10 2008 1141 1150
18. M. Cirillo, C. Ciacci, and N.G. De Santo Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults N Engl J Med 359 8 2008 864 866
19. Meng J, Ohlsson C, Laughlin GA, et al. Sex hormones and serum phosphorus in older men: the Osteoporotic Fractures in Men (MrOs) Study. Kidney Int, in press.
20. B. Ruo, J. Rumsfeld, M. Hlatky, H. Liu, W. Browner, and M. Whooley Depressive symptoms and health-related quality of life: the Heart and Soul Study JAMA 2 290 2003 215 221
21. J.H. Ix, G.M. Chertow, M.G. Shlipak, V.M. Brandenburg, M. Ketteler, and M.A. Whooley Fetuin-A and kidney function in persons with coronary artery diseasedata from the Heart and Soul Study Nephrol Dial Transplant 21 8 2006 2144 2151
22. R. Lang, M. Bierig, R. Devereux Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 12 18 2005 1440 1463
23. M. Turakhia, N. Schiller, and M. Whooley Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study) Am J Cardiol 102 2008 1131 1135
24. J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, and M.A. Whooley Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study Circulation 113 14 2006 1760 1767
25. J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2 2007 173 179
26. L.A. Stevens, J. Coresh, and C.H. Schmid Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 3 2008 395 406
27. B.A. Perkins, R.G. Nelson, and B.E. Ostrander Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study J Am Soc Nephrol 16 5 2005 1404 1412
28. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
29. D. DuBois, and E.F. DuBios A formula to estimate the approximate surface area if height and weight are known Arch Intern Med 17 1916 863 871
30. F. Anan, H. Yonemochi, and T. Masaki High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension Hypertens Res 2 30 2007 125 131
31. Y. Iwashima, T. Horio, K. Kamide, H. Rakugi, T. Ogihara, and Y. Kawano C-Reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension Hypertens Res 12 30 2007 1177 1185
32. A. Moran, R. Katz, and N. Jenny Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the Multi-Ethnic Study of Atherosclerosis (MESA) Am J Kidney Dis 52 5 2008 839 848
33. M. Smebye, E. Iversen, and A. Høieggen Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE Study) Am J Cardiol 5 100 2007 855 859
34. M.D. Krailo, and M.C. Pike Estimation of the distribution of age at natural menopause from prevalence data Am J Epidemiol 117 3 1983 356 361
35. C. Castelo-Branco, M. Martnez de Osaba, F. Pons, and J. Gonzlez-Merlo The effect of hormone replacement therapy on postmenopausal bone loss Eur J Obstet Gynecol Reprod Biol 2 44 1992 131 136
36. J.L. Stock, J.A. Coderre, and L.E. Mallette Effects of a short course of estrogen on mineral metabolism in postmenopausal women J Clin Endocrinol Metab 61 4 1985 595 600
37. Y. Liel, S. Shany, P. Smirnoff, and B. Schwartz Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa Endocrinology 140 1 1999 280 285
38. N. Carrillo-Lopez, P. Roman-Garcia, A. Rodriguez-Rebollar, J.L. Fernandez-Martin, M. Naves-Diaz, and J.B. Cannata-Andia Indirect regulation of PTH by estrogens may require FGF23 J Am Soc Nephrol 20 9 2009 2009 2017